1. Hereditary transthyretin amyloidosis: baseline characteristics of patients in the NEURO-TTR trial. (3rd July 2018) Authors: Waddington-Cruz, Marcia; Ackermann, Elizabeth J.; Polydefkis, Michael; Heitner, Stephen B.; Dyck, Peter J.; Barroso, Fabio A.; Wang, Annabel K.; Berk, John L.; Dyck, P. James B.; Monia, Brett P.; Hughes, Steven G.; Tai, Li; Jesse Kwoh, T.; Jung, Shiangtung W.; Coelho, Teresa; Benson, Merrill D.; ... Journal: Amyloid Issue: Volume 25:Number 3(2018) Page Start: 180 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Suppressing transthyretin production in mice, monkeys and humans using 2nd-Generation antisense oligonucleotides. (2nd July 2016) Authors: Ackermann, Elizabeth J.; Guo, Shuling; Benson, Merrill D.; Booten, Sheri; Freier, Sue; Hughes, Steven G.; Kim, Tae-Won; Jesse Kwoh, T.; Matson, John; Norris, Dan; Yu, Rosie; Watt, Andy; Monia, Brett P. Journal: Amyloid Issue: Volume 23:Number 3(2016:Sep.) Page Start: 148 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗